Grant Holder |
Researcher |
Current project Institute Amount Awarded Duration Type of Award |
Regulating breast tumour cell survival through Bcl-x proteins: implications for therapeutic responses.
Dr Harvey's project is a continuation of previous Campaign funding. She will investigate a molecule called Brk, which she believes protects breast cancer cells from being destroyed by chemotherapy treatment.
This research may ultimately help make chemotherapy treatments more successful and help to lower the dosage of chemotherapy required (and therefore reducing the side effects experience by patient)